Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 2/2019

07.09.2018 | Reproductive Physiology and Disease

Detailed endometrial immune assessment of both normal and adverse reproductive outcome populations

verfasst von: Kevin Marron, David Walsh, Conor Harrity

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Using a comprehensive flow cytometric panel, do endometrial immune profiles in adverse reproductive outcomes such as repeat implantation failure (RIF) and repeat pregnancy loss (RPL) differ from each other and male-factor controls?

Methods

Six-hundred and twelve patients had an endometrial biopsy to assess the immunophenotype. History on presentation was used to subdivide the population into recurrent implantation failure (RIF) [n = 178], recurrent pregnancy loss (RPL) [n = 155], primary infertility [n = 130] and secondary infertility [n = 114]. A control group was utilised for comparative purposes [n = 35] and lymphocyte subpopulations were described.

Results

Distinct lymphocyte percentage differences were noted across the populations. Relative to controls and RPL, patients with a history of RIF had significantly raised uterine NKs (53.2 vs 45.2 & 42.9%, p < 0.0001). All sub-fertile populations had increased percentage peripheral type NKs (p = 0.001), and exhibited increased CD69+ activation (p = 0.005), higher levels of B cells (p < 0.001), elevated CD4:CD8 ratio (p < 0.0001), lower T-regs (p = 0.034) and a higher proportion of Th1+ CD4s (p = 0.001). Patient aetiology confers some distinct findings, RPL; pNK, Bcells and CD4 elevated; RIF; uNK and CD56 raised while CD-8 and NK-T lowered.

Conclusions

Flow cytometric endometrial evaluation has the ability to provide a rapid and objective analysis of lymphocyte subpopulations. The findings show significant variations in cellular proportions of immune cells across the patient categories relative to control tissue. The cell types involved suggest that a potential differential pro-inflammatory bias may exist in patients with a history of adverse reproductive outcomes. Immunological assessment in appropriate populations may provide insight into the underlying aetiology of some cases of reproductive failure.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lathi RB, Westphal LM, Milki AA. Aneuploidy in the miscarriages of infertile women and the potential benefit of preimplanation genetic diagnosis. Fertil Steril. 2008;89(2):353–7.CrossRefPubMed Lathi RB, Westphal LM, Milki AA. Aneuploidy in the miscarriages of infertile women and the potential benefit of preimplanation genetic diagnosis. Fertil Steril. 2008;89(2):353–7.CrossRefPubMed
3.
Zurück zum Zitat Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SEM, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22(1):116–33.CrossRefPubMed Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SEM, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22(1):116–33.CrossRefPubMed
4.
Zurück zum Zitat Bozdag G, Aksan G, Esinler I, Yarali H. What is the role of office hysteroscopy in women with failed IVF cycles? Reprod BioMed Online. 2008;17(3):410–5.CrossRefPubMed Bozdag G, Aksan G, Esinler I, Yarali H. What is the role of office hysteroscopy in women with failed IVF cycles? Reprod BioMed Online. 2008;17(3):410–5.CrossRefPubMed
5.
Zurück zum Zitat Riccio L, et al. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018;50:39–49.CrossRefPubMed Riccio L, et al. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018;50:39–49.CrossRefPubMed
6.
Zurück zum Zitat Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod BioMed Online. 2006;13(1):29–37.CrossRefPubMed Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod BioMed Online. 2006;13(1):29–37.CrossRefPubMed
7.
Zurück zum Zitat Di Simone N, et al. Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of beta(2) glycoprotein I. Am J Reprod Immunol. 2013;70(4):299–308.CrossRefPubMed Di Simone N, et al. Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of beta(2) glycoprotein I. Am J Reprod Immunol. 2013;70(4):299–308.CrossRefPubMed
8.
Zurück zum Zitat Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515–22.CrossRefPubMed Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515–22.CrossRefPubMed
10.
Zurück zum Zitat Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014;72(2):129–40.CrossRefPubMed Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014;72(2):129–40.CrossRefPubMed
11.
Zurück zum Zitat Hill JA. Immunological contributions to recurrent pregnancy loss. Baillieres Clin Obstet Gynaecol. 1992;6(3):489–505.CrossRefPubMed Hill JA. Immunological contributions to recurrent pregnancy loss. Baillieres Clin Obstet Gynaecol. 1992;6(3):489–505.CrossRefPubMed
12.
Zurück zum Zitat Franasiak JM, Scott RT. Contribution of immunology to implantation failure of euploid embryos. Fertil Steril. 2017;107(6):1279–83.CrossRefPubMed Franasiak JM, Scott RT. Contribution of immunology to implantation failure of euploid embryos. Fertil Steril. 2017;107(6):1279–83.CrossRefPubMed
13.
Zurück zum Zitat Lucas ES, Dyer NP, Murakami K, Hou Lee Y, Chan YW, Grimaldi G, et al. Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells. 2016;34(2):346–56.CrossRefPubMed Lucas ES, Dyer NP, Murakami K, Hou Lee Y, Chan YW, Grimaldi G, et al. Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells. 2016;34(2):346–56.CrossRefPubMed
14.
Zurück zum Zitat Steer CV, Campbell S, Tan SL, Crayford T, Mills C, Mason BA, et al. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril. 1992;57(2):372–6.CrossRefPubMed Steer CV, Campbell S, Tan SL, Crayford T, Mills C, Mason BA, et al. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril. 1992;57(2):372–6.CrossRefPubMed
15.
Zurück zum Zitat Diaz-Gimeno P, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50–60. 60.e1–15CrossRefPubMed Diaz-Gimeno P, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril. 2011;95(1):50–60. 60.e1–15CrossRefPubMed
16.
Zurück zum Zitat Moffett A, Shreeve N. Reply: first do no harm: continuing the uterine NK cell debate. Hum Reprod. 2016;31(1):218–9.CrossRefPubMed Moffett A, Shreeve N. Reply: first do no harm: continuing the uterine NK cell debate. Hum Reprod. 2016;31(1):218–9.CrossRefPubMed
17.
18.
Zurück zum Zitat van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol. 2009;85(1):4–19.CrossRefPubMed van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol. 2009;85(1):4–19.CrossRefPubMed
19.
Zurück zum Zitat Savasi VM, Mandia L, Laoreti A, Cetin I. Maternal and fetal outcomes in oocyte donation pregnancies. Hum Reprod Update. 2016;22(5):620–33.CrossRefPubMed Savasi VM, Mandia L, Laoreti A, Cetin I. Maternal and fetal outcomes in oocyte donation pregnancies. Hum Reprod Update. 2016;22(5):620–33.CrossRefPubMed
20.
Zurück zum Zitat Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod. 2011;26(8):1971–80.CrossRefPubMed Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod. 2011;26(8):1971–80.CrossRefPubMed
21.
Zurück zum Zitat Russell P, Sacks G, Tremellen K, Gee A. The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. III: further observations and reference ranges. Pathology. 2013;45(4):393–401.CrossRefPubMed Russell P, Sacks G, Tremellen K, Gee A. The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. III: further observations and reference ranges. Pathology. 2013;45(4):393–401.CrossRefPubMed
22.
Zurück zum Zitat Laird, L., Li, Bulmer, <RCOG 2016 guidelines.pdf>. 2016. Laird, L., Li, Bulmer, <RCOG 2016 guidelines.pdf>. 2016.
23.
Zurück zum Zitat Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065–74.CrossRefPubMed Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065–74.CrossRefPubMed
24.
Zurück zum Zitat Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod. 1995;10(Suppl 2):14–21.CrossRefPubMed Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod. 1995;10(Suppl 2):14–21.CrossRefPubMed
25.
Zurück zum Zitat Lédée N, Petitbarat M, Chevrier L, Vitoux D, Vezmar K, Rahmati M, et al. The uterine immune profile may help women with repeated unexplained embryo implantation failure after in vitro fertilization. Am J Reprod Immunol. 2016;75(3):388–401.CrossRefPubMedPubMedCentral Lédée N, Petitbarat M, Chevrier L, Vitoux D, Vezmar K, Rahmati M, et al. The uterine immune profile may help women with repeated unexplained embryo implantation failure after in vitro fertilization. Am J Reprod Immunol. 2016;75(3):388–401.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Lachapelle MH, et al. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol. 1996;156(10):4027–34.PubMed Lachapelle MH, et al. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol. 1996;156(10):4027–34.PubMed
27.
Zurück zum Zitat Ledee N, et al. Specific and extensive endometrial deregulation is present before conception in IVF/ICSI repeated implantation failures (IF) or recurrent miscarriages. J Pathol. 2011;225(4):554–64.CrossRefPubMed Ledee N, et al. Specific and extensive endometrial deregulation is present before conception in IVF/ICSI repeated implantation failures (IF) or recurrent miscarriages. J Pathol. 2011;225(4):554–64.CrossRefPubMed
29.
Zurück zum Zitat Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod BioMed Online. 2006;13(1):24–8.CrossRefPubMed Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod BioMed Online. 2006;13(1):24–8.CrossRefPubMed
30.
Zurück zum Zitat Vassiliadou N, Bulmer JN. Immunohistochemical evidence for increased numbers of ‘classic’ CD57+ natural killer cells in the endometrium of women suffering spontaneous early pregnancy loss. Hum Reprod. 1996;11(7):1569–74.CrossRefPubMed Vassiliadou N, Bulmer JN. Immunohistochemical evidence for increased numbers of ‘classic’ CD57+ natural killer cells in the endometrium of women suffering spontaneous early pregnancy loss. Hum Reprod. 1996;11(7):1569–74.CrossRefPubMed
31.
Zurück zum Zitat Alecsandru D, Garcia-Velasco JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril. 2017;107(6):1273–8.CrossRefPubMed Alecsandru D, Garcia-Velasco JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril. 2017;107(6):1273–8.CrossRefPubMed
32.
Zurück zum Zitat Laufer N, Simon A. Recurrent implantation failure: current update and clinical approach to an ongoing challenge. Fertil Steril. 2012;97(5):1019–20.CrossRefPubMed Laufer N, Simon A. Recurrent implantation failure: current update and clinical approach to an ongoing challenge. Fertil Steril. 2012;97(5):1019–20.CrossRefPubMed
33.
Zurück zum Zitat Medicine, T.P.C.o.t.A.S.f.R., Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility, 2012. 98(5): p. 1103–1111. Medicine, T.P.C.o.t.A.S.f.R., Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and Sterility, 2012. 98(5): p. 1103–1111.
34.
Zurück zum Zitat ESHRE, <ESHRE RPL Guideline_28112017_FINAL.pdf>. 2017. ESHRE, <ESHRE RPL Guideline_28112017_FINAL.pdf>. 2017.
35.
Zurück zum Zitat Burkhard SH, Mair F, Nussbaum K, Hasler S, Becher B. T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. PLoS One. 2014;9(4):e94196.CrossRefPubMedPubMedCentral Burkhard SH, Mair F, Nussbaum K, Hasler S, Becher B. T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. PLoS One. 2014;9(4):e94196.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26(1):44–62.CrossRefPubMed Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26(1):44–62.CrossRefPubMed
37.
Zurück zum Zitat Marci R, Gentili V, Bortolotti D, Lo Monte G, Caselli E, Bolzani S, et al. Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility. PLoS One. 2016;11(7):e0158304.CrossRefPubMedPubMedCentral Marci R, Gentili V, Bortolotti D, Lo Monte G, Caselli E, Bolzani S, et al. Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility. PLoS One. 2016;11(7):e0158304.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Coulam CB, Bilal M, Salazar Garcia MD, Katukurundage D, Elazzamy H, Fernandez EF, et al. Prevalence of HHV-6 in endometrium from women with recurrent implantation failure. Am J Reprod Immunol. 2018;80:e12862.CrossRefPubMed Coulam CB, Bilal M, Salazar Garcia MD, Katukurundage D, Elazzamy H, Fernandez EF, et al. Prevalence of HHV-6 in endometrium from women with recurrent implantation failure. Am J Reprod Immunol. 2018;80:e12862.CrossRefPubMed
39.
Zurück zum Zitat Siewiera J, el Costa H, Tabiasco J, Berrebi A, Cartron G, Bouteiller P, et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog. 2013;9(4):e1003257.CrossRefPubMedPubMedCentral Siewiera J, el Costa H, Tabiasco J, Berrebi A, Cartron G, Bouteiller P, et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog. 2013;9(4):e1003257.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003;101(8):3052–7.CrossRefPubMed Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003;101(8):3052–7.CrossRefPubMed
41.
Zurück zum Zitat Petitbarat M, Rahmati M, Sérazin V, Dubanchet S, Morvan C, Wainer R, et al. TWEAK appears as a modulator of endometrial IL-18 related cytotoxic activity of uterine natural killers. PLoS One. 2011;6(1):e14497.CrossRefPubMedPubMedCentral Petitbarat M, Rahmati M, Sérazin V, Dubanchet S, Morvan C, Wainer R, et al. TWEAK appears as a modulator of endometrial IL-18 related cytotoxic activity of uterine natural killers. PLoS One. 2011;6(1):e14497.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, et al. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol. 2011;90(1):105–10.CrossRefPubMed Fukui A, Funamizu A, Yokota M, Yamada K, Nakamua R, Fukuhara R, et al. Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J Reprod Immunol. 2011;90(1):105–10.CrossRefPubMed
43.
Zurück zum Zitat Thiruchelvam U, Wingfield M, O'Farrelly C. Natural killer cells: key players in endometriosis. Am J Reprod Immunol. 2015;74(4):291–301.CrossRefPubMed Thiruchelvam U, Wingfield M, O'Farrelly C. Natural killer cells: key players in endometriosis. Am J Reprod Immunol. 2015;74(4):291–301.CrossRefPubMed
44.
45.
Zurück zum Zitat Hviid MM, Macklon N. Immune modulation treatments—where is the evidence? Fertil Steril. 2017;107(6):1284–93.CrossRefPubMed Hviid MM, Macklon N. Immune modulation treatments—where is the evidence? Fertil Steril. 2017;107(6):1284–93.CrossRefPubMed
46.
Zurück zum Zitat Alecsandru D, Garcia-Velasco JA. Immune testing and treatment: still an open debate. Hum Reprod. 2015;30(8):1994.CrossRefPubMed Alecsandru D, Garcia-Velasco JA. Immune testing and treatment: still an open debate. Hum Reprod. 2015;30(8):1994.CrossRefPubMed
47.
Zurück zum Zitat Sacks G. Enough! Stop the arguments and get on with the science of natural killer cell testing. Hum Reprod. 2015;30(7):1526–31.CrossRefPubMed Sacks G. Enough! Stop the arguments and get on with the science of natural killer cell testing. Hum Reprod. 2015;30(7):1526–31.CrossRefPubMed
48.
Zurück zum Zitat Ledee N, et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J Reprod Immunol. 2018;127:11–5.CrossRefPubMed Ledee N, et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J Reprod Immunol. 2018;127:11–5.CrossRefPubMed
49.
Zurück zum Zitat Potdar N, Gelbaya T, Nardo LG. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod BioMed Online. 2012;25(6):561–71.CrossRefPubMed Potdar N, Gelbaya T, Nardo LG. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod BioMed Online. 2012;25(6):561–71.CrossRefPubMed
50.
Zurück zum Zitat Gnainsky Y, Granot I, Aldo PB, Barash A, Or Y, Schechtman E, et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril. 2010;94(6):2030–6.CrossRefPubMedPubMedCentral Gnainsky Y, Granot I, Aldo PB, Barash A, Or Y, Schechtman E, et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril. 2010;94(6):2030–6.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Nastri, C.O., et al., Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev, 2015(3): p. Cd009517. Nastri, C.O., et al., Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev, 2015(3): p. Cd009517.
52.
Zurück zum Zitat Reljic M, et al. Endometrial injury, the quality of embryos, and blastocyst transfer are the most important prognostic factors for in vitro fertilization success after previous repeated unsuccessful attempts. J Assist Reprod Genet. 2017;34(6):775–9.CrossRefPubMedPubMedCentral Reljic M, et al. Endometrial injury, the quality of embryos, and blastocyst transfer are the most important prognostic factors for in vitro fertilization success after previous repeated unsuccessful attempts. J Assist Reprod Genet. 2017;34(6):775–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Detailed endometrial immune assessment of both normal and adverse reproductive outcome populations
verfasst von
Kevin Marron
David Walsh
Conor Harrity
Publikationsdatum
07.09.2018
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 2/2019
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1300-8

Weitere Artikel der Ausgabe 2/2019

Journal of Assisted Reproduction and Genetics 2/2019 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.